Search PubMed⌕ Search

Biomedical subjects

J Crane

Publications and source records attributed to J Crane.

At least 73 records · Page 4Linked to original sources

Receptor-triggered membrane association of a model retroviral glycoprotein.

Current models of retroviral entry hypothesize that interactions between the viral envelope protein and the host receptor(s) induce conformational changes in the envelope protein that activate the envelope protein and initiate fusion. We employed a liposome-binding assay to demonstrate directly and characterize the activation of a model retroviral envelope protein (EnvA) from Rous sarcoma virus (RSV). In the presence of purified viral receptor, the trimeric ectodomain of EnvA was converted from a water-soluble form to a membrane-associated form, consistent with conversion of the envelope protein to its fusogenic state. This activation was nonlinear with respect to receptor concentration, suggesting cooperativity within the trimeric envelope protein. The activated EnvA was stably associated with the target membrane through hydrophobic interactions, behaving like an intrinsic membrane protein. The ability of EnvA to associate with membrane was coincident with a loss of receptor-binding activity, suggesting that during viral entry activated EnvA dissociates from the receptor to facilitate membrane fusion. These results provide direct evidence that receptor binding triggers conversion of the EnvA protein to a membrane-binding form, illustrating that RSV is a useful model for the study of retroviral entry and activation of pH-independent fusion proteins.

3T3 Cells↗

The extrapulmonary effects of increasing doses of formoterol in patients with asthma.

OBJECTIVE: To assess the cardiovascular and metabolic responses to increasing doses of formoterol administered from a dry powder inhaler. METHODS: Twenty patients with mild to moderate asthma were given 12, 24, 48 and 96 microg of formoterol or a matched placebo on separate days. The doses were administered using a randomised, cross-over, double-blind design. The effects on heart rate, blood pressure, electromechanical systole (QS2I), the electrocardiographic QTc interval, plasma potassium (K); blood glucose and FEV1 were assessed prior to, and for 9 h following each dose. RESULTS: There was no difference between the maximum effects of formoterol 12 microg and placebo; the 24 microg dose significantly decreased plasma K (-0.2 mmol x l(-1)) and increased blood glucose (1.8 mmol x l(-1)) compared to placebo. The two highest doses affected most of the variables with the 96 microg dose being significantly different from placebo for all indices, heart rate (9 beats x min(-1)), systol BP (4 mmHg), diastolic BP (-3 mmHg), QS2I (-11 ms), QTc (17 ms), plasma K (-0.5 mmol x l(-1)) and blood glucose (2.6 mmol x l(-1)). All doses of formoterol increased FEV1. CONCLUSION: Although there were dose-dependent effects on the extrapulmonary measurements, only the effects at the highest dose may be of clinical significance.

Administration, Inhalation↗

Biologic pollution in infant bedding in New Zealand: high allergen exposure during a vulnerable period.

BACKGROUND: High exposure to house dust mite and cat allergens in early life predisposes to allergic sensitization and to the development and persistence of asthma. Prevalence and severity of asthma are high in New Zealand. OBJECTIVE: The objective of this study was to determine the concentrations of Der p 1 and Fel d 1 in infant bedding in Wellington, New Zealand. METHODS: Infants were visited at home at a mean age of 11 weeks and again at 15 months. The concentration (microgram/g fine dust) and content (microgram/m2) of Der p 1 (154 infants) and Fel d 1 (75 infants) were measured in dust samples taken from each infant's bed. RESULTS: At 11 weeks, geometric mean (95% confidence intervals) Der p 1 levels were 18.3 micrograms/g (13.8 to 24.1) and 3.51 micrograms/m2 (2.4 to 5.2). By 15 months, Der p 1 had risen significantly to 44.0 micrograms/g (35.0 to 55. 3) and 49.0 micrograms/m2 (36.0 to 66.8). Bedding that included a sheepskin was used by a third of the infants and contained higher concentrations (microgram/g) and content (microgram/m2) of Der p 1 than beds without sheepskins. Cat ownership was the major determinant of Fel d 1 levels, with 48% of infants living with cats. At the first visit, the mean concentration of Fel d 1 in bedding was 44.6 micrograms/g (23.5 to 84.9) for houses with cats and 3.0 micrograms/g (2.1 to 4.3) for those without cats, remaining essentially unchanged at the second visit. When expressed as micrograms per square meter, there was a significant increase between visits, from 8.1 (3.9 to 16. 6) to 39.6 (19.9 to 78.5) in the cat-inclusive households. CONCLUSIONS: Extremely high levels of house dust mite allergen have been found in these infants' environments, which, together with the high levels of cat allergen in almost half who kept cats, are likely to be a major determinant of asthma prevalence and severity in New Zealand.

Allergens↗

A pilot study of the effect of mechanical ventilation and heat exchange on house-dust mites and Der p 1 in New Zealand homes.

We have examined the effect of reducing relative humidity (RH), with inbuilt mechanical ventilation and heat-exchange (MVHE) units, on house-dust-mite (HDM) counts and allergen levels, in a pilot study of 10 Wellington dwellings. Recent international prevalence studies in adults and children have confirmed a high prevalence of asthma in New Zealand. Sensitivity to HDM is common among the general population, and HDM is the major allergen associated with asthma. Recent studies of allergen levels have confirmed high concentrations of Der p 1 in the domestic environment. While humidity was significantly reduced in those dwellings fitted with ventilation units, no systematic effect on mites or Der p 1 was observed during the study period. When the reductions in humidity were examined in the context of the time spent below the critical equilibrium humidity (CEH), the intervention led to RH values below the CEH for only 39% of the total of 24-h periods for which measurements were made. Reducing RH by means of MVHE in New Zealand domestic dwellings does not lower humidity sufficiently, or long enough, to have any measurable effect on HDM populations.

Allergens↗

Case-control study of salmeterol and near-fatal attacks of asthma.

BACKGROUND: A case-control study was undertaken to investigate the hypothesis that the use of the long acting beta agonist salmeterol increases the risk of a near-fatal attack of asthma. METHODS: The cases comprised admissions to the intensive care unit (ICU) for asthma in 14 major hospitals within the Wessex region in 1992. For each of the cases four age-matched controls were selected from asthma admissions to the same hospital during the same period. Information on prescribed drug therapy for the 48 cases and 185 controls was collected from the hospital admission records. RESULTS: The patients admitted to the ICU had greater chronic asthma severity and had generally been prescribed more asthma drugs than the control admissions to hospital. The relative risk of a near-fatal attack of asthma in patients prescribed inhaled salmeterol was 2.32 (95% CI 1.05 to 5.16), p = 0.04. However, the salmeterol relative risk decreased to 1.42 (95% CI 0.49 to 4.10), p = 0.52 when the analysis was restricted to the more chronically severe patients (those in the subgroup of patients with a hospital admission for asthma in the previous 12 months). These findings suggest that the increased unadjusted relative risk with salmeterol is predominantly due to confounding by severity--that is, the increased relative risk is due to patients with more severe asthma (at greatest risk of a near-fatal asthma attack) being preferentially prescribed salmeterol. This interpretation is supported by the finding in this study that, within the control group (selected from the population of asthmatics requiring hospital admission), salmeterol was preferentially prescribed to the most severe patients (a threefold greater prescription of salmeterol to control patients if they had been admitted to hospital in the 12 months prior to the index admission). There was no increased risk of a near-fatal attack of asthma in patients prescribed a beta agonist by metered dose inhaler (OR 0.75 (95% CI 0.31 to 1.78), p = 0.51). In contrast, the relative risks for beta agonists delivered by nebulisation (OR 3.86 (95% CI 1.99 to 7.50), p < 0.001) and oral theophylline (OR 2.45 (95% CI 1.26 to 4.78), p < 0.01) were increased and did not markedly decrease when the analysis was restricted to the more severe asthmatic subjects. CONCLUSIONS: Although these findings are not conclusive, particularly because of the small numbers involved in some subgroup analyses, they suggest that the use of salmeterol by patients with chronic severe asthma is not associated with a significantly increased risk of a near-fatal attack of asthma. If a near-fatal asthma attack is considered to be an intermediate step in a process by which a severe attack of asthma may become fatal, these results would suggest that salmeterol is unlikely to be associated with an increased risk of death, at least by this mechanism.

Adolescent↗

Prevalence of adult asthma symptoms in relation to climate in New Zealand.

We conducted an ecological study linking prevalence of adult asthma symptoms with climate in the 93 New Zealand general electorates. For each electorate, the 12-month period prevalence of self-reported asthma symptoms was determined using a random sample of adults aged 20-44 on the 1991 New Zealand electoral roll. Long-term average climate was estimated using a national climate database and a geographic information system. Asthma prevalence was calculated within quartiles of the exposure variables. Independent effects of climate variables were assessed using linear regression models, with adjustment for confounding by climate, social deprivation, and geographic variables. There was a statistically significant association between asthma prevalence and mean temperature, with the lowest quartile of mean temperature having an approximately 2% lower asthma prevalence. After adjusting for confounding, there was a monotonic increase in asthma prevalence within quartiles of temperature. The results of this study are in agreement with other research suggesting a lower prevalence of asthma at low temperatures. Although on short (day-to-day) time scales, low temperatures may have a direct effect resulting in acute exacerbations of asthma symptoms, warmer average temperatures are associated with increased asthma prevalence. The reasons for this are unclear, although it is possible that on longer term (annual) time scales, higher temperatures are associated with higher levels of allergen exposure.

Adult↗

Long-term reduction in asthma morbidity following an asthma self-management programme.

The adult "credit card" asthma self-management plan has been shown to be an effective and acceptable system for reducing asthma morbidity when introduced as part of a 6 month community-based asthma programme. The aim of the present study was to assess the effectiveness of the credit card plan 2 yrs after the end of the programme. Markers of asthma morbidity and use of medical services were compared during the 12 months before enrolment, and 2 yrs after completing the 6 month asthma programme. Of the 69 participants who originally enroled in the 6 month asthma programme, 58 were surveyed 2 yrs after completion of the programme. These participants showed a significant improvement in all but one of the asthma morbidity measures. The proportion waking most nights with asthma in the previous 12 months decreased from 29 to 9% (p=0.02), emergency visits to a general practitioner decreased from 43 to 16% (p=0.001), hospital emergency department visits with asthma decreased from 19 to 5% (p=0.02) and hospital admissions decreased from 17 to 5% (p=0.04). Only 24% of patients reported that they usually monitored their peak flow rate daily, but this increased to 73% during a "bad" attack of asthma. A long-term reduction in asthma morbidity and requirement for acute medical services can result following the introduction of the adult credit card asthma self-management plan. Adult patients with asthma are most likely to undertake peak flow monitoring preferentially during periods of unstable asthma, rather than routinely during periods of good control.

Adult↗

The effect of frequent vacuum cleaning on the house dust mite allergen, Der p 1 in carpets: a pilot study.

AIM: To determine the effect of frequent vacuum cleaning of carpets on Der p 1, the major group one allergen of the house dust mite Dermatophagoides pteronyssinus. METHODS: Nine rooms and three hallways in the resident medical officers quarters at Wellington Hospital were regularly vacuum cleaned (daily, except weekends) over a five week period. Dust samples were collected before and at weekly intervals for Der p 1 measurement by a double monoclonal antibody ELISA technique. RESULTS: Der p 1 concentrations progressively declined from an initial geometric mean level (95% CI) of 4.47 micrograms/g fine dust (0.11-21.73) to 1.83 micrograms/g (0.29-9.57) after five weeks, a mean reduction of 48.0% (31.7-65.5). Similarly when expressed per unit area Der p 1 levels declined from 6.35 micrograms/m2 (1.15-35.16) to 1.66 micrograms/m2 (0.33-9.04), a mean reduction of 68.5% (58.6-78.3). CONCLUSIONS: Frequent vacuum cleaning over a short time significantly reduces house dust mite allergen levels in carpets. Larger long term trials are warranted to determine if greater reductions are possible that would be beneficial to house dust mite sensitive individuals.

Animals↗

Right medial temporal-lobe contribution to object-location memory.

An important aspect of normal human memory, and one humans share with many other species, is the ability to remember the location of objects in their environment. There is by now strong evidence from the study of epileptic patients undergoing brain surgery that right temporal-lobe lesions that encroach extensively upon the hippocampal and parahippocampal gyrus impair the delayed, but not the immediate, recall of the location of objects within a random array. These findings have now been extended to a multiple-trial, spatial-array learning task; by including not only patients tested after unilateral anterior temporal lobectomy but also those with a selective left or right amygdalohippocampectomy, it has been shown that the deficits associated with right hippocampal lesions are not dependent upon conjoint damage to the lateral temporal neocortex. Furthermore, the fact that on the learning task no group differences were seen on Trial 1, at zero delay, strengthened the view that the impairment was in the maintenance and subsequent retrieval of information rather than in its initial encoding. These results left unresolved the question of whether the deficit was in the mediation of object-place associations or whether it could be reduced to a more general impairment in memory for location as such. Also left unanswered was the neuroanatomical question as to the relative contributions of the hippocampus and the parahippocampal gyrus to the performance of the experimental tasks. These questions were addressed in two blood-flow activation studies that made use of positron emission tomography (PET) and magnetic resonance imaging (MRI) and incorporated computerized versions of object-location and simple-location memory tasks. Taken together, the results point to a special contribution from the anterior part of the right parahippocampal gyrus, probably corresponding to the entorhinal cortex, to the retrieval of object-place associations, a result consonant with neurophysiological findings in non-human primates.

Hippocampus↗

Respiratory questionnaire responses: how they change with time.

AIM: Responses to respiratory questionnaires are often used to identify individuals with asthma symptoms and may also be used to identify asymptomatic individuals. This study investigates the repeat responses over four years to such a questionnaire in a population of adult New Zealanders. METHODS: Seven hundred and twenty three asthmatics were sent two almost identical questionnaires in three areas of New Zealand, separated by approximately four years. All of them had answered yes to at least one of the three questions under study in the first survey. RESULTS: Following the second asthma questionnaire only 487 (67.4%) answered yes to at least one of the survey questions. Similarly, 51.1% of those who had reported having nocturnal shortness of breath in the first survey did so in the second survey, 69.9% of those who reported having had an asthma attack in the first survey did so in the second survey, and finally 74.8% of those who reported using asthma medication in the first survey did so in the second survey. CONCLUSION: Even in a previously identified symptomatic asthmatic group, a large proportion did not report respiratory symptoms and asthma medication use four years later. This implies that the true prevalence pool of susceptibles is likely to be far greater than is identified in surveys of the 12-month period prevalence of asthma symptoms. This has implications not only for the design of epidemiological studies (e.g., it poses problems for the selection of a control group of non-asthmatics in prevalence case-control studies), but also for the planning of health services and educational programmes for people with asthma.

Adult↗

Geographical variation in the prevalence of asthma symptoms in New Zealand.

AIMS: To examine geographical variations in the prevalence of asthma symptoms in a random population sample of New Zealand adults aged 20-44 years. METHODS: A one page asthma symptom questionnaire was sent to 31470 people aged 20-44 years. The questionnaire asked about respiratory symptoms, asthma attacks and asthma treatment. Those who had not responded after two reminder postcards were followed with a telephone call where possible. RESULTS: A response rate of 82% (25664) was achieved. The 12 month period prevalence of asthma (defined as woken by shortness of breath, or an attack of asthma in the past year, or current asthma medication) was 15.2% overall, but was higher in females (17.0%) than in males (13.2%); the prevalence was 22.1% in Maori, 20.6% in Pacific Islanders and 14.3% in non Polynesians. In North Island electorates, the highest age and ethinicity standardised prevalences were found in some of the electorates in the Auckland and Wellington urban regions although prevalence was also high in some rural electorates including Raglan (18.0%), Horowhenua (18.4%) and Wairarapa (18.4%); the lowest prevalences were found in other rural electorates including King Country (5.5%), Matamata (10.1%) and Rotorua (10.3%). In South Island electorates, the highest prevalences were found in some electorates in the Christchurch and Dunedin urban areas, and the lowest prevalences were again found in rural electorates including Clutha (11.3%), Rangiora (9.5%) and Wallace (9.4%). CONCLUSIONS: This study confirms the previously reported high frequency of asthma symptoms in New Zealand adults, with higher symptom prevalence in Maori and in women. It shows significant urban/rural differences, as well as marked differences in prevalence between various rural areas. The reasons for these patterns are unclear and require further study.

Adult↗

Occupational asthma and other nonasbestos occupational respiratory diseases notified between 1993 and 1996.

AIM: To review notifications to the Occupational Safety and Health Service of the Department of Labour Notifiable Occupational Disease System since its inception until June 1996. METHODS: All notifications received for non asbestos related occupational respiratory disease were reviewed to evaluate the outcome of the notification and to identify the causative agent where possible. RESULTS: There were 277 cases notified and investigated including worksite investigations. Of these 73 cases were confirmed as having occupational asthma, 35 by the asthma validation panel. Nineteen cases of other occupational respiratory disease were notified of which 11 were reviewed by the panel. Extrinsic allergic alveolitis secondary to organic dusts was the most common such notification. CONCLUSIONS: Isocyanates are well recognised as a cause of occupational asthma in New Zealand. It is suspected that occupational asthma and other occupational respiratory diseases are poorly notified to this system. Better mechanisms are needed to identify occupational causes of respiratory (and other) disease.

Asthma↗